Retinoic acid receptors in hematopoiesis

Current Topics in Microbiology and Immunology

Volumn 211, Issue , 1996, Pages 6-15

  Collins, Steven J ^a   Tsai, Schickwann ^a   Bernstein, Irwin ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ANIMAL CELL; CELL DIFFERENTIATION; CELL LINE; CONFERENCE PAPER; HEMATOPOIESIS; HUMAN; HUMAN CELL; MOUSE; MYELOID LEUKEMIA; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

HEMATOPOIESIS; HUMANS; NEUTROPHILS; RECEPTORS, RETINOIC ACID; RETINOIDS; STEM CELL FACTOR;

ANIMALIA;

EID: 0030071060     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-85232-9_2     Document Type: Article

References (15)

1. Andrews R, Singer J, Bernstein I: Human hematopoietic precursors in long-term culture: single CD34+ cells that lack detectable T cell, B cell, and myeloid cell antigens produce multiple colony-forming cells when cultured with marrow stromal cells. J Exp Med 172: 355, 1990.
2. Apfel C., Bauer F., Crettaz M., et al. A retinoic acid receptor α antagonist selectively counteracts retinoic acid effects. Proc. Natl. Acad. Sci. USA 89: 7129-7133, 1992.
3. - cells cultured with IL-3, G-CSF or GM-CSF. Blood 77: 2316, 1991.
4. Breitman T, Selonick S, Collins S: Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77: 2936, 1980.
5. Castaigne S, Chomienne C, Daniel M et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical Results Blood 76: 1704, 1990.
6. Collins SJ, Robertson K, and Mueller L: Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RARα). Mol Cell Biol 10: 2154, 1990.
7. Collins S, Gallo R, and Gallagher R: Continuous growth and differentiation of human myeloid leukemia cells in suspension culture. Nature 270: 347, 1977.
8. de The H, Marchio A, Tiollais P, and Dejean A. Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes. EMBO J. 8: 429., 1989.
9. Evans R: The steroid and thyroid hormone receptor superfamily. Science 240: 889, 1988.
10. Huang M, Ye YC, Chen SR et al. Use of all trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567, 1988.
11. Terstappen LWMM, Huang S, Safford M et al. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. Blood 77: 1218, 1991.
12. Tsai S, Bartelmez S, Heyman R, Damm K, Evans R, Collins S: A mutated retinoic acid receptor alpha exhibiting dominant negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes and Development 6: 2258, 1992.
13. Tsai S, and Collins S: A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc Natl Acad Sci USA 90: 7153, 1993.
14. Tsai S., Bartelmez, S, Sitnicka E., and Collins S. Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant negative retinoic acid receptor can recapitulate lymphoid, myeloid and erythroid development. Genes and Development 8: 2831, 1994.
15. Warrell R, Frankel S, Miller W et al. Differentiation therapy of acute promyelocytic leukemia with treretinoin (all-trans retinoic acid). New Engl. J. Med 324: 1385, 1991